Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

Front Physiol · 2012 · PMC3385353 · PMID 22754534

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendP = 0.057so close (0.05 < p ≤ 0.1)

placebo in 402 patients at high-risk for fatal ventricular arrhythmias showed a trend toward a reduction of the primary endpoint (risk reduction of −28% of the time to the first ICD event for VT or VF, or death from any cause; P = 0.057).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.